Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function.

Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function.

Impaired glucose tolerance is associated with an increased risk of Type 2 diabetes. This prospective cohort study has examined the variables associated with hyperglycaemic progression in order to elucidate the aetiology of this deterioration. The 5 mg glucose.kg ideal body weight.min-1 continuous in...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Cook, J, Page, R, Levy, J, Hammersley, MS, Walravens, E, Turner, R
Natura:	Journal article
Lingua:	English
Pubblicazione:	1993

Documenti analoghi

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
di: Page, R, et al.
Pubblicazione: (1993)

Prevalence and pathophysiology of impaired glucose tolerance in three different high-risk white groups.
di: Page, R, et al.
Pubblicazione: (1993)

GLUCOSE-TOLERANCE AND BETA-CELL FUNCTION ASSESSED BY CONTINUOUS INFUSION OF GLUCOSE AND ORAL GLUCOSE-TOLERANCE TEST
di: Levy, J, et al.
Pubblicazione: (1992)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
di: Hermans, M, et al.
Pubblicazione: (1996)

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.
di: McLellan, J, et al.
Pubblicazione: (1995)

Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance.
di: Levy, J, et al.
Pubblicazione: (1999)

Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance
di: Levy, J, et al.
Pubblicazione: (1999)

Hyperglycaemic Hemichorea
di: Joana Silva Marques, et al.
Pubblicazione: (2018-02-01)

MEASUREMENT OF INSULIN-RESISTANCE AND BETA-CELL FUNCTION - THE HOMA AND CIGMA APPROACH
di: Turner, R, et al.
Pubblicazione: (1993)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
di: Anke Tönjes, et al.
Pubblicazione: (2010-01-01)

Correction: Common Variants in the Type 2 Diabetes Gene Are Associated with Impairments in Insulin Secretion During Hyperglycaemic Glucose Clamp.
di: Jana V. van Vliet-Ostaptchouk, et al.
Pubblicazione: (2012-01-01)

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes.
di: Hermans, M, et al.
Pubblicazione: (1999)

Hormonal and metabolic responses to glucose infusion during exercise using the hyperglycaemic glucose clamp technique
di: MacLaren, D, et al.
Pubblicazione: (1992)

The updated HOMA model: comparison of performance against euglycaemic and hyperglycaemic clamps
di: Wallace, T, et al.
Pubblicazione: (2004)

Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects.
di: Cook, J, et al.
Pubblicazione: (1993)

Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp.
di: Jana V van Vliet-Ostaptchouk, et al.
Pubblicazione: (2012-01-01)

IMPAIRED BETA-CELL FUNCTION BUT NOT SELECTIVE GLUCOSE INSENSITIVITY IN DIET-TREATED TYPE-2 DIABETIC SUBJECTS
di: Camps, I, et al.
Pubblicazione: (1993)

COMPARISON OF THE ABILITY OF 3 IN-VIVO TESTS TO DISCRIMINATE DIFFERENCES IN BETA-CELL FUNCTION OVER THE RANGE OF GLUCOSE-TOLERANCE
di: Hermans, M, et al.
Pubblicazione: (1995)

The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.
di: Karunakaran, S, et al.
Pubblicazione: (1997)

Anti-hyperglycaemic activity of tuber extract of Chlorophytum alismifolium Baker in streptozotocin-induced hyperglycaemic rats
di: Abdulhakim Abubakar, et al.
Pubblicazione: (2018-06-01)

Correction: Common Variants in the Type 2 Diabetes KCNQ1 Gene Are Associated with Impairments in Insulin Secretion During Hyperglycaemic Glucose Clamp
Pubblicazione: (2012-01-01)

Hyperglycaemic siblings of type 2 diabetic patients have greater central obesity than their normoglycaemic siblings but similar physical activity indices
di: Herlihy, O, et al.
Pubblicazione: (1998)

SERUM URIC ACID LEVEL IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE AS COMPARED TO SUBJECTS WITH NORMAL GLUCOSE TOLERANCE
di: Muhammad Zubair, et al.
Pubblicazione: (2019-10-01)

Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance
di: Wascher Thomas C, et al.
Pubblicazione: (2006-04-01)

The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose.
di: Dyson, P, et al.
Pubblicazione: (1997)

Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance
di: Eugene Han, et al.
Pubblicazione: (2020-06-01)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
di: QinJie Li, et al.
Pubblicazione: (2022-10-01)

Predictive factors for hyperglycaemic progression in patients with schizophrenia or bipolar disorder
di: Ichiro Kusumi, et al.
Pubblicazione: (2018-11-01)

Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance.
di: Szelachowska Malgorzata, et al.
Pubblicazione: (2003-05-01)

Hypoxia mimetics restore bone biomineralisation in hyperglycaemic environments
di: Azadeh Rezaei, et al.
Pubblicazione: (2022-08-01)

Glyoxal in hyperglycaemic ischemic stroke – a cohort study
di: Sina Rhein, et al.
Pubblicazione: (2023-07-01)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
di: Preiss, D, et al.
Pubblicazione: (2013)

MECHANISM OF NON-ESTERIFIED FATTY-ACID SUPPRESSION DURING GLUCOSE INFUSIONS - IMPAIRMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC SUBJECTS AND THEIR RELATIVES
di: Levy, J, et al.
Pubblicazione: (1989)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
di: Yupu Liu, et al.
Pubblicazione: (2022-02-01)

Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
di: Levy, J, et al.
Pubblicazione: (1991)

Statin treatment is associated with greater hyperglycaemic response to a glucagon challenge
di: R. Mamidi, et al.
Pubblicazione: (2023-12-01)

Impaired glucose tolerance in sleep disorders.
di: Marietta Keckeis, et al.
Pubblicazione: (2010-03-01)

Study of Impaired Glucose Tolerance in Pulmonary Tuberculosis
di: Jain MK, et al.
Pubblicazione: (2006-01-01)

Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
di: Thomas Pixner, et al.
Pubblicazione: (2024-07-01)

Influence of moderate physical activity on the levels of plasma lipoproteins in subjects with impaired glucose tolerance
di: Petković-Košćal Milanka, et al.
Pubblicazione: (2012-01-01)